In CRC, berberine prevents the growth, migration and invasion of CRC cells in vitro and in vivo by targeting the COX-2/PGE2-JAK2 and STAT3-MMP-2/MMP-9 signaling pathways 159. Here, MMP9 is linked to colorectal carcinoma.